PDM may represent a novel and “atypical” DAT pharmacotherapeutic approach for the cocaine addiction treatment via combined DAT inhibition (PDM) and DAT substrate (PM) mechanisms. The gene discussed is SLC6A3; the disease is cocaine dependence.